Search clinical trials for: MDMA, LSD, psilocybin

Total 2007 results

Felix Mueller
Swiss Society for Psycholytic Therapy (SÄPT)

Enrolling by invitation

The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training (TherPsySE)

Personal Experience of Substance-assisted Therapy Using Psilocybin, MDMA, and LSD

Switzerland
Usona Institute
Worldwide Clinical Trials

Recruiting

Psilocybin for Major Depressive Disorder (MDD) (uAspire)

Depressive Disorder, Major

United States
University of Wisconsin, Madison
Tiny Blue Dot Foundation

Not yet recruiting

Pairing Psilocybin With Transcutaneous Auricular Vagus Nerve Stimulation (ENHANCE)

Healthy | Vagus Nerve Stimulation | Psychedelic Experiences

United States
Peking University Cancer Hospital & Institute

Not yet recruiting

First Human Trial of Targeting MDM2/MDMX PET Imaging

Nuclear Medicine | MDM2/MDMX Gene Mutation | Positron Emission Tomography Imaing
University of California, San Francisco
Filament Health

Recruiting

Comparing the Effects of Psilocin and Psilocybin in Healthy Adults

Healthy

United States
University of Zurich

Completed

Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self

Healthy
University of Wisconsin, Madison

Completed

Pilot RECAP Study in Healthy Volunteers (RECAP)

Psychedelic Experiences | Amnesia

United States
University Hospital, Basel, Switzerland

Completed

Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin (LSD-psilo)

Healthy

Switzerland
United States Army Research Institute of Environmental...
US Army Research and Development Command- Soldier Center

Completed

Effects of Energy and Physical Density Manipulation on Appetite

Eating Behavior | Appetite

United States
University of Zurich
Schweizerischer Nationalfonds

Completed

Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept

Depressive Disorder, Major

Switzerland
University of Washington
Steven & Alexandra Cohen Foundation

Active, not recruiting

Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer

Metastatic Malignant Solid Neoplasm | Hematopoietic and Lymphatic System Neoplasm

United States
Willa Hall

Not yet recruiting

MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers

Adjustment Disorders | Post-Traumatic Stress Disorder
Remedy
Multidisciplinary Association for Psychedelic Studies

Active, not recruiting

A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)

Post Traumatic Stress Disorder

Canada
Usona Institute
The Emmes Company, LLC

Completed

A Study of Psilocybin for Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States
Usona Institute

Completed

An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics

Pharmacokinetics | QTc Interval

United States
Cumhuriyet University

Completed

Exploring the Complex Links Between Menstrual Irregularity and Cellular Markers

Menstrual Irregularity | Menstrual Cycle Abnormal

Turkey
Hawler Medical University

Completed

Low Carbohydrate Diet Versus Low Fat Diet in Reversing the Metabolic Syndrome Using NCEP ATP III Criteria

Metabolic Syndrome
University Hospital, Basel, Switzerland

Completed

Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects (LSD-MDMA)

Healthy

Switzerland
University of Wisconsin, Madison
Usona Institute; Tiny Blue Dot Foundation

Enrolling by invitation

Consciousness, Psilocybin, and Well-Being (CoPE Pilot)

Healthy | Sleep | Psychedelic Experiences

United States
Yale University
Heffter Research Institute; Ceruvia Lifesciences; CH TAC LLC

Completed

Psilocybin for the Treatment of Cluster Headache

Cluster Headache

United States
University of Chicago

Completed

Drug Effects on Interpersonal Interaction (DEI)

Interaction, Social

United States
University of Chicago

Completed

Effects of Drugs on Responses to Brain and Emotional Processes (MAT)

Healthy | Autism Spectrum Disorder

United States
Ulrika Morris
Uppsala University; University of California, San Francisco; RTI International; Mahidol Oxford Tropical Medicine Research Unit and other collaborators

Completed

Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in Zanzibar (MaDrAZ)

Malaria | Plasmodium Infections

Tanzania
University of Wisconsin, Madison
TRYP Therapeutics

Withdrawn

Bioavailability Study of Psilocybin in Normal Adults

Healthy

United States
Bryan Tompson

Completed

The Effect of Light Emitting Diode Phototherapy on the Rate of Orthodontic Tooth Movement - A Clinical Study

The Rate or Orthodontic Tooth Movement

Canada
Yale University
Ceruvia Lifesciences

Completed

Psilocybin for the Treatment of Migraine Headache

Migraine Headache

United States
University Hospital, Basel, Switzerland

Active, not recruiting

Effects of MDMA-like Substances in Healthy Subjects (MDMA-like)

Healthy

Switzerland
King's College London
University of Cambridge

Recruiting

Psilocybin in Adults With and Without Autism Spectrum Disorder (PSILAUT)

Autism Spectrum Disorder

United Kingdom
Yale University
Heffter Research Institute

Active, not recruiting

Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

Major Depressive Disorder

United States
Section for Affective Disorders; Northern Stockholm...
Karolinska Institutet; Vastra Gotaland Region; Region Örebro County; Uppsala University...

Recruiting

Cancer Related Major Depression Treated With a Single Dose of Psilocybin (CAPSI)

MDD

Sweden
University of Arizona

Active, not recruiting

Psilocybin for Treatment of Obsessive Compulsive Disorder (PSILOCD)

Obsessive-compulsive Disorder (OCD)

United States
University Health Network, Toronto
Centre for Addiction and Mental Health

Recruiting

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin (PSI-1V2)

Depression | Mood Disorders | Major Depressive Disorder | Treatment-Resistant Depression

Canada
Yale University

Terminated

Effects of Psilocybin in Concussion Headache

Post-Traumatic Headache

United States
Lykos Therapeutics

Completed

Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder

Posttraumatic Stress Disorder

United States
University of Colorado, Denver

Not yet recruiting

Psilocybin for Treatment-Resistant Depression

Anhedonia | Major Depressive Disorder | Treatment Resistant Depression

United States
Gitte Moos Knudsen

Recruiting

The Neurobiological Effect of 5-HT2AR Modulation (NeuroPharm2)

Basic Science

Denmark
Multidisciplinary Association for Psychedelic Studies

Withdrawn

Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma

Anxiety | Stage IV Melanoma

United States
Spaulding Rehabilitation Hospital
Multidisciplinary Association for Psychedelic Studies

Not yet recruiting

MDMA-assisted Therapy for Fibromyalgia

Fibromyalgia

United States
Johns Hopkins University
Private Philanthropic Funds

Not yet recruiting

Safety for Home Administration of Microdose Psilocybin Use

Psychedelic Experiences
University of California, Los Angeles

Not yet recruiting

MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents

Psychotherapy | Adolescents | PTSD, Post Traumatic Stress Disorder

United States
Lykos Therapeutics

Completed

Randomized, Double-blind, Active Placebo-Controlled Pilot Study of MDMA-assisted Psychotherapy in People With Chronic PTSD

Posttraumatic Stress Disorder (PTSD)

Israel
Rotem Petranker
Nikean Foundation

Recruiting

Microdosing Psychedelics to Improve Mood

Major Depressive Disorder

Canada
University of Southern California
Multidisciplinary Association for Psychedelic Studies

Active, not recruiting

Epigenetics and MDMA-Assisted Psychotherapy for PTSD

PTSD

United States
Beersheva Mental Health Center

Not yet recruiting

Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD

Obsessive-compulsive Disorder
Centre Hospitalier Universitaire de Nīmes

Not yet recruiting

Psilocybin in Alcohol Use Disorder With Comorbid Depression (PAD)

Depressive Disorder | Alcohol-Related Disorders | Addiction

France
University of Southern California

Not yet recruiting

Mindfulness-assisted Psychedelic Therapy (MAPT)

Mental Health

United States
University of Otago

Enrolling by invitation

Psilocybin-assisted Interpersonal Therapy for Depression

Depressive Disorder, Treatment-Resistant

New Zealand
Washington University School of Medicine

Active, not recruiting

Precision Functional Brain Mapping in Psilocybin (Psilocybin PFM)

Psilocybin

United States
Johns Hopkins University

Completed

Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators

Psilocybin | Therapeutic Uses | Psychotropic Drugs | Hallucinogens | Pharmacologic Actions | Central Nervous System Agents

United States
Anya Bershad, MD, PhD
National Institutes of Health (NIH)

Not yet recruiting

Tolerability of MDMA in Schizophrenia (TMS)

Schizophrenia

Search clinical trials for: MDMA, LSD, psilocybin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations